Product Description
Product Name: Everolimus
CAS NO: 159351-69-6
MF: C53H83NO14
MW: 958.22
Appearance: White Powder
Description: Everolimus is a derivative of sirolimus, also known as 40-O-(2-hydroxyethyl)-rapamycin, or 40-O-(2-hydroxyethyl)-sirolimus, It belongs to the kinase class of drugs that interfere with cell communication to prevent bad cell growth. It is an oral mammalian rapamycin (mTOR) inhibitor. In the past, it was mainly used to prevent rejection after kidney transplantation and heart transplantation.
Detailed Photos
Function
Everolimus macrolide immunosuppressant
Everolimus is a derivative of rapamycin
Everolimus inhibits cytokine-mediated lymphocyte proliferation
Company Profile
Recommended products
Capecitabine |
Everolimus |
Afatinib |
Vandetanib |
Gefitinib |
Temozolomid |
Rapamycin |
Axitinib |
Sorafenib tosylate |
Cediranib |
Cabozantinib |
Selumetinib |
Crizotinib |
Sunitinib malate |
Erlotinib |
Crizotinib |
Lapatinib |
Debrafenib |
Cabazitaxel |
Ponatinib |
FAQ
1. Customs clearance
1) By Express:
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
2. Payment
T/T,Western Union,MoneyGram,Trade Assurance Order,L/C etc.